HEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE

Size: px
Start display at page:

Download "HEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE"

Transcription

1 HEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE Author: Jenny Boyce, Lead Infection Prevention & Control Nurse Approved by and date: March 2016 Any other linked ICP Infection Prevention and Control Assurance Policies: Framework ICP Standard Precaution Policy Cleaning and Disinfection Procedure Decontamination Policy Outbreak Procedure Isolation Procedure Procedure number: ICPr006 Version control: Version 1:

2 Version Date Date of Next Reason for Change (eg. full No. Ratified/ Implementation Review rewrite, amendment to reflect Amended Date new legislation, updated flowchart, minor amendments, etc.) 1 01/03/16 30/09/2018 Changed from policy to procedure Page 2

3 TABLE OF CONTENTS 1. INTRODUCTION IDENTIFYING RISK OF INFECTION Communication Risk Assessment Risk assessment checklist Risk factors for contracting healthcare associated MRSA Risk Factors for Clostridium difficile-associated Diarrhoea Risk of Carbapenemase-producing Enterobacteriacea (CPE) REFERENCES AND BIBLIOGRAPHY APPENDIX 1 - Equality considerations... 8 APPENDIX 2 RISK ASSESSMENT TOOL FOR MENTAL HEALTH AND LEARNING DISABILITY SERVICES... 9 APPENDIX 3 RISK ASSESSMENT TOOL FOR Community Services Page 3

4 1. INTRODUCTION Healthcare associated infection (HCAI) risk assessments are undertaken to determine the risk of a patient contracting or spreading a healthcare associated infection and aids care planning and patient placement and transfer or discharge. A HCAI risk assessment should be undertaken on admission, transfer and if necessary on discharge of patients, using the risk assessment tool shown in Appendix 1, as part of the patient s assessment record on SystmOne or epex system. If completed prior to transfer or discharge to another hospital, or other care facility or where follow up by community staff is required, a copy of the assessment form should be included with the transfer/discharge summary paperwork which accompanies patient. 2. IDENTIFYING RISK OF INFECTION 2.1 Communication The presence of some infectious diseases such as MRSA does not usually prevent patient transfer to another ward or unit however; good communication before transfer will ensure that correct management measures are taken to reduce risks of spread. Good communication with the receiving facility within the Trust or external healthcare organisation will help determine e.g. whether the patient needs isolation facility or not. The Infection Prevention and Control Team (IP&CT) must be involved early in the management of HCAIs at the earliest opportunity. 2.2 Risk Assessment Once a risk assessment has been undertaken and infection hazards identified then an individual care plan must be put in place to minimise the risks. The patient and or the family must be informed of the status. This will include what level of personal protective equipment is needed, accommodation for patient, how to deal with any wounds, equipment management and if necessary transfer. For cases of MRSA or C.diff the integrated care pathway contained in the ICP006 and ICP007 policies must be used and any concerns must be discussed with the Infection Prevention and Control Team. A number of questions should be addressed when formulating the infection control care plan: Question What is the source or likely source of the infectious organism? How does the organism spread? Example Blood, faeces, urine or sputum. Direct or indirect contact, airborne or faecal oral.

5 Question Are there additional risk factors? What is the general mental and physical health of the patient? Are other patients, staff or visitors at risk? Availability of staff and facilities? What could be contaminated? Example Indwelling devices, wounds, antibiotics, incontinence, diarrhoea, impaired immunity, age, environmental conditions and Staff practice. Underlying diseases, dementia, immobility and poor personal hygiene. Sharing rooms, pregnant staff or visitors, older patients. Isolation facility, adequate staffing levels. Hands, face, clothing, linen, equipment and environment Risk assessment checklist The risk assessment checklist Appendix 2 & 3 contained in this procedure will assist you in deciding on the level of infection risk the patient faces or poses to others. The more Yes selected the higher the infection risk Risk factors for contracting healthcare associated MRSA Current or recent hospitalisation. MRSA remains a concern in hospitals, where it can attack those most vulnerable such as older adults and people with weakened immune systems and or recent surgery. Open wounds or burn, skin conditions or serious underlying health problems. Residing in a long-term care facility. MRSA is also prevalent in these facilities and carriers of MRSA have the ability to spread it, even if they're not showing signs of infection. Invasive devices. People who are catheterised, intravenous drips in situ or have feeding tubes or other invasive devices in situ are at higher risk. NB: If yes to questions marked * on assessment checklist, then patient should be considered high risk for MRSA acquisition and MRSA screening should be undertaken and if screening positive discuss further actions with IP&CT Risk Factors for Clostridium difficile-associated Diarrhoea Advanced age. Antibiotic therapy - The overuse of antibiotics, especially penicillin (ampicillin), clindamycin and cephalosporins. Placement of nasogastric tube. Prolonged hospital stay. Repeated enemas. Gastrointestinal tract surgery Sharing a room with a C.diff infected patient. Use of antacids Page 5

6 C. difficile-associated disease occurs when the normal intestinal flora is altered, allowing C. difficile to flourish in the intestinal tract and produce a toxin that causes a watery diarrhoea. The environment and equipment and hands can become contaminated and help to spread the infection Risk of Carbapenemase-producing Enterobacteriacea (CPE). Been in-patients in a hospital abroad, Serious medical conditions, Received multiple antibiotics, Complex surgery, Stayed in an intensive Care Unit, Insertion of foreign materials such as urinary catheters, ventilators or intravenous catheters. CPE is a group of bacteria that have become very resistant to antibiotics including those called carbapenems such as meropenem. Many of these bacteria usually live harmlessly in the gut of humans or animals and help digest food. However, if they get into the wrong place such as the bladder or blood stream they can cause infection such as urinary tract infections, wound infections and pneumonia. 3. REFERENCES AND BIBLIOGRAPHY Antibiotics: 'national threat' from steep rise in patients who are resistant to drugs. The Daily Telegraph, March Antibiotic resistance soars: Cases of gut bacteria not destroyed by drugs increase by 12,000% in seven years. Mail Online, March Department of Health (2007), Essential Steps to safe, clean care Inter-healthcare patient infection risk assessment form DH: London Fears that cases of antibiotic-resistant bacteria could get 'out of control'. The Independent, March The Health and Social Care Act 2008: Code of Practice on the prevention and control of infections and related guidance (2010) h_ pdf epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England (due for publication in the Journal of Hospital Infection January 2014) Page 6

7 Public Health England. Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae (PDF 1.6Mb). March 2014 UK Standards for Microbiology Investigations: Laboratory Detection and Reporting of Bacteria with Carbapenem-Hydrolysing β-lactamases (carbapenemases) (2013) published at: Page 7

8 4. APPENDIX 1 - EQUALITY CONSIDERATIONS The Trust has a duty under the Equality Act and the Public Sector Equality Duty to assess the impact of Policy changes for different groups within the community. In particular, the Trust is required to assess the impact (both positive and negative) for a number of protected characteristics including: Age; Disability; Gender reassignment; Marriage and civil partnership; Race; Religion or belief; Sexual orientation; Pregnancy and maternity; and Other excluded groups and/or those with multiple and social deprivation (for example carers, transient communities, ex-offenders, asylum seekers, sex-workers and homeless people). The author has considered the impact on these groups of the adoption of this Policy and does not believe that there are any specific equality considerations that need to be taken into account. Page 8

9 APPENDIX 2 RISK ASSESSMENT TOOL FOR MENTAL HEALTH AND LEARNING DISABILITY SERVICES Admission Transfer Date... Patient/Service User details Name: Consultant: DOB: GP: Address Current Patient Location: MRSA Yes No N/K Is the patient known to be infected or colonised with MRSA? Has the patients been previously positive to MRSA? Has the patient had an MRSA screen undertaken? *Has the patient any wounds/skin lesions/pressure sores/leg ulcers? *Has the patient a history of frequent acute hospital admissions? Has the patient any indwelling devices i.e. urethral catheters, supra-pubic catheters and peg sites? If yes: Where...When... Result...(N/K = Not Known) NB: If yes to all questions * consider high risk and undertake MRSA screening as per procedure. If MRSA positive on admission or positive on screening please use integrated pathway in the procedure. Diarrhoea Yes No N/K Does the patient have diarrhoea? Is the diarrhoea thought to be of an infectious nature? Has a specimen been sent? Has an organism been identified? If yes: Where...When... Result... Has patient had treatment? If yes: What...and when completed... NB: Patients with diarrhoea caused by Clostridium difficile toxins or enteric pathogens such as E.coli or salmonella should be isolated in single room until 48 hours symptom free. There is also an integrated Clostridium difficile pathway available in the Procedure for the management of Clostridium difficile. Other communicable disorders Does the patient has or is suspected of having any of the following communicable disorders: Chicken pox or Smear positive TB Influenza Impetigo Scabies shingles Other please specify... Page 9

10 APPENDIX 3 RISK ASSESSMENT TOOL FOR COMMUNITY SERVICES The screenshot below is where the staff identify the level of risk of infection. All System One users must complete this form.

11

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas This toolkit includes examples advice leaflets and forms which may be helpful for use by teams or

More information

Disclosure Status (B) B Can be disclosed to patients and the public

Disclosure Status (B) B Can be disclosed to patients and the public Policy: ICP12 MRSA Policy Version: ICP12/V7 Ratified by: Trust Management Team Date ratified: 11 March 2015 Title of Author: Infection Control Nurse Title of responsible Director Director of Nursing &

More information

TRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO)

TRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO) TRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO) Reference Number POL- IC/1082/14 Version 1.2.0 Status Final Author: Helen Forrest

More information

Infection Prevention and Control. Carbapenemase Producing Enterobacteriaceae (CPE)

Infection Prevention and Control. Carbapenemase Producing Enterobacteriaceae (CPE) Infection Prevention and Control Carbapenemase Producing Enterobacteriaceae (CPE) IPCT CPE Policy V4 May 2018 Policy Title: Executive Summary: Carbapenemase Producing Enterobacteriaceae (CPE) This policy

More information

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Prevention and Control of Infection in Care Homes Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Content for today Importance of IPAC -refresher IPAC audits in

More information

Reducing the risk of healthcare associated infection

Reducing the risk of healthcare associated infection i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can

More information

CARBAPENEMASE PRODUCING ENTEROBACTERICAE (CPE): COMMUNITY TOOLKIT

CARBAPENEMASE PRODUCING ENTEROBACTERICAE (CPE): COMMUNITY TOOLKIT CARBAPENEMASE PRODUCING ENTEROBACTERICAE (CPE): COMMUNITY TOOLKIT Rick Catlin 04/04/18 CPE Carbapenemase producing enterobactericae Gut bacteria (enterobactericae) that have developed resistance to multiple

More information

Infection Prevention and Control Policy

Infection Prevention and Control Policy Infection Prevention and Control Policy Version: 2 V Ratified By: Quality Sub Committee R Date Ratified: vember 2016 D Date Policy Comes Into Effect: vember 2016 D Author: Karen Taylor A Responsible Director:

More information

Reducing the risk of healthcare associated infection

Reducing the risk of healthcare associated infection i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can

More information

Section G - Aseptic Technique. Version 5

Section G - Aseptic Technique. Version 5 Section G - Aseptic Technique Version 5 Important: This document can only be considered valid when viewed on the Trust s Intranet. If this document has been printed or saved to another location, you must

More information

Reducing HCAI- What the Commissioner needs to know.

Reducing HCAI- What the Commissioner needs to know. Reducing HCAI- What the Commissioner needs to know. Sarah Mantle HCAI/AMR project lead NHS England #NHSEngAMR Do Tweet Introduction Healthcare Associated Infections (HCAI) can develop as a result of direct

More information

INFECTION PREVENTION AND CONTROL. Multi- Resistant Gram Negative Bacilli Including E.coli and Acinetobacter Species Policy

INFECTION PREVENTION AND CONTROL. Multi- Resistant Gram Negative Bacilli Including E.coli and Acinetobacter Species Policy INFECTION PREVENTION AND CONTROL Multi- Resistant Gram Negative Bacilli Including E.coli and Acinetobacter Species Policy IPCT Multi-Resistant Gram Negative Bacilli Policy, V4, Dec 16 Page 1 Policy Title:

More information

Carbapenemase-Producing Enterobacteriaceae (CPE) and Carbapenemase-Producing Organisms (CPO)

Carbapenemase-Producing Enterobacteriaceae (CPE) and Carbapenemase-Producing Organisms (CPO) Carbapenemase-Producing Enterobacteriaceae (CPE) and Carbapenemase-Producing Organisms (CPO) Information for patients and visitors This leaflet explains how we test for, treat and prevent the spread of

More information

Definitions. Healthcare Acquired Infection (HCAI)

Definitions. Healthcare Acquired Infection (HCAI) Infection Prevention and Control Assurance - Standard Operating Procedure 21 (IPC SOP 21) Alert Organisms Glycopeptide Resistant Enterococci (GRE) and Vancomycin Resistant Enterococci (VRE) Why we have

More information

Developed in response to: Best Practice Infection Prevention and Control

Developed in response to: Best Practice Infection Prevention and Control Transfer of patients within MEHT Clinical Guideline Developed in response to: Best Practice Infection Prevention and Control Version Number 1.0 Issuing Directorate Corporate Governance Approved by Clinical

More information

Clostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions

Clostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions Page 1 of 9 Standard Operating procedure (SOP) Objective To provide HCWs with details of the care required to prevent cross-infection in children s with Clostridium difficile Infection (CDI). This SOP

More information

Section J - Management of Patients with Multi Resistant Organisms:

Section J - Management of Patients with Multi Resistant Organisms: Section J - Management of Patients with Multi Resistant Organisms: Carbapenemase-Producing Enterobacteriaceae (CPE) Vancomycin-Resistant Enterococci (VRE) Penicillin-Resistant Pneumococci (PRP) Extended

More information

NHS Professionals. POL6 Infection Control Policy

NHS Professionals. POL6 Infection Control Policy NHS Professionals POL6 Infection Control Policy Content Page Number Introduction 2 Scope of policy 2 Organisational structure and framework 3 Corporate Responsibilities 3 Partnership with NHS Trusts 4

More information

Job Title 22 February 2013

Job Title 22 February 2013 Surveillance of Infection Policy HH(1)/IC/613/13 Previous document(s) being replaced Location Policy Policy Name RHCH CP021 Surveillance Policy BNHH IC/289/09 Surveillance of Infection Protocol Document

More information

Alert Organisms Multi-Resistant Gram Negative Bacteria (MR-GNB) excluding MRSA

Alert Organisms Multi-Resistant Gram Negative Bacteria (MR-GNB) excluding MRSA Infection Prevention and Control Assurance - Standard Operating Procedure 22 (IPC SOP 22) Alert Organisms Multi-Resistant Gram Negative Bacteria (MR-GNB) excluding MRSA Why we have a procedure? To ensure

More information

METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE. Purpose of Issue/Description of Change

METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE. Purpose of Issue/Description of Change METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE First Issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date 10/2008 1 Guidance

More information

ASSESSMENT ACTIVITY ANSWER PACK

ASSESSMENT ACTIVITY ANSWER PACK ASSESSMENT ACTIVITY ANSWER PACK 1 Assessment Activity 1: What is Source Isolation?.. Briefly summarise why some patients require Source Isolation Care. Some patients infected or colonised with certain

More information

Direct cause of 5,000 deaths per year

Direct cause of 5,000 deaths per year HOSPITAL ACQUIRED (NOSOCOMIAL) INFECTION Policies MRSA Policy Meningitis Policy Blood and body fluid Exposure Policy Disinfection Policy Glove Policy Tuberculosis Policy Isolation Policy DEFINITION: ANY

More information

PROCEDURE FOR TAKING A WOUND SWAB

PROCEDURE FOR TAKING A WOUND SWAB CLINICAL PROCEDURE PROCEDURE FOR TAKING A WOUND SWAB Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date 2 To provide a standardised process of the fundamental principles

More information

your hospitals, your health, our priority CATHETERISATION Urethral/ supra-pubic POLICY NAME: VERSION NUMBER : 1 PROFESSIONAL ADVISORY BOARD (PAB)

your hospitals, your health, our priority CATHETERISATION Urethral/ supra-pubic POLICY NAME: VERSION NUMBER : 1 PROFESSIONAL ADVISORY BOARD (PAB) POLICY NAME: POLICY REFERENCE: CATHETERISATION Urethral/ supra-pubic TW12/016 VERSION NUMBER : 1 APPROVING COMMITTEE: PROFESSIONAL ADVISORY BOARD (PAB) DATE THIS VERSION APPROVED: RATIFYING COMMITTEE:

More information

Includes GP flow chart & out of hours protocols. Page 1 of 11

Includes GP flow chart & out of hours protocols. Page 1 of 11 Clostridium Difficile Policy. Precautions to be observed when caring for ECCH in-patients colonised or infected with Clostridium Difficile (C.difficile) Includes GP flow chart & out of hours protocols

More information

Infection Prevention Control Team

Infection Prevention Control Team Title Document Type Document Number Version Number Approved by Infection Control Manual Section 3.1 Isolation Precautions and Infection Control Care Plan Policy 3 rd Edition Infection Control Committee

More information

MRSA in Holland What is Behind the Success Gertie van Knippenberg-Gordebeke

MRSA in Holland What is Behind the Success Gertie van Knippenberg-Gordebeke MRSA situations in Holland: What is behind the success? ICP, VieCuri Medical Centre Venlo, The Netherlands Hosted by Paul Webber paul@webbertraining.com www.webbertraining.com INFECTION CONTROL HISTORY

More information

01/09/2014. The very first requirement in a hospital is that it should do the sick no harm!!!!

01/09/2014. The very first requirement in a hospital is that it should do the sick no harm!!!! Infection Prevention and Control A Foundation Course Update on recent Guidelines and Recommendations Ros Cashman Cork University Maternity Hospital, Cork 2014 The very first requirement in a hospital is

More information

Infection Prevention and Control Carbapenemase producing Enterobacteriaceae (CPE) Policy

Infection Prevention and Control Carbapenemase producing Enterobacteriaceae (CPE) Policy Infection Prevention and Control Carbapenemase producing Enterobacteriaceae (CPE) Policy East Cheshire NHS Trust Infection Prevention and Control CPE V3 March 2016 1 Policy Title: Executive Summary: Carbapenemase

More information

DISCHARGE AND TRANSFER POLICY FOR MENTAL HEALTH AND LEARNING DISABILITIES

DISCHARGE AND TRANSFER POLICY FOR MENTAL HEALTH AND LEARNING DISABILITIES DISCHARGE AND TRANSFER POLICY FOR MENTAL HEALTH AND LEARNING DISABILITIES Policy Details NHFT document reference CLP056 Version Version 8 01.05.2015 Date Ratified 01.09.2015 Ratified by Trust Policy Board

More information

Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0

Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0 Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0 01.05.2018 Summary - Patient admission flow chart for the infection prevention and control of carbapenemase-producing

More information

Healthcare associated infections across the health and social care community

Healthcare associated infections across the health and social care community Healthcare associated infections across the health and social care community Professor Brian Duerden CBE Inspector of Microbiology and Infection Control, Department of Health, London Infection is different..it

More information

Self-Instructional Packet (SIP)

Self-Instructional Packet (SIP) Self-Instructional Packet (SIP) Advanced Infection Prevention and Control Training Module 4 Transmission Based Precautions February 11, 2013 Page 1 Learning Objectives Module One Introduction to Infection

More information

Consumers Union/Safe Patient Project Page 1 of 7

Consumers Union/Safe Patient Project Page 1 of 7 Improving Hospital and Patient Safety: An overview of recently passed legislation and requirements towards improving the safety of California s hospital patients June 2009 Background Since 2006 several

More information

Lightning Overview: Infection Control

Lightning Overview: Infection Control Lightning Overview: Infection Control Gary Preston, PhD, CIC, FSHEA Terry Caton, CIC Carla Ward, CIC 2012 Healthcare Management Alternatives, Inc. Objectives At the end of this module you will know: How

More information

Infection Control Prevention Strategies. For Clinical Personnel

Infection Control Prevention Strategies. For Clinical Personnel Infection Control Prevention Strategies For Clinical Personnel What is Infection Control? Infection Control is EVERYONE s responsibility It protects patients, employees and visitors by preventing and controlling

More information

ASEPTIC & CLEAN (NON TOUCH TECHNIQUE) POLICY

ASEPTIC & CLEAN (NON TOUCH TECHNIQUE) POLICY ASEPTIC & CLEAN (NON TOUCH TECHNIQUE) POLICY First Issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date 4 Update September 2012 Named Responsible Officer:- Approved by

More information

The role of HIQA in Quality Improvement in Long-Term Care. Bríd McGoldrick Inspector Manager HIQA

The role of HIQA in Quality Improvement in Long-Term Care. Bríd McGoldrick Inspector Manager HIQA The role of HIQA in Quality Improvement in Long-Term Care Bríd McGoldrick Inspector Manager HIQA Overview Regulations and Standards Annual Overview Report 2015 Governance Communication Regulation Directorate

More information

Procedure for the Management and Control of Carbapenemase-producing Enterobacteriaceae (CPE)

Procedure for the Management and Control of Carbapenemase-producing Enterobacteriaceae (CPE) SH CP 177 Procedure for the Management and Control of Carbapenemase-producing Enterobacteriaceae (CPE) Infection Prevention and Control Policy: Appendix 21 Version 2 Summary: Defines the actions and management,

More information

Best Practice Guidelines BPG 5 Catheter Care

Best Practice Guidelines BPG 5 Catheter Care Best Practice Guidelines BPG 5 Catheter Care BGP 5 1 DOCUMENT STATUS: Reviewed DATE ISSUED: March 2014 DATE TO BE REVIEWED: 13.10.17 AMENDMENT HISTORY VERSION DATE AMENDMENT HISTORY V1 March 2014 New Guideline

More information

Infection Prevention and Control Assurance

Infection Prevention and Control Assurance Infection Prevention and Control Assurance Who Should Read This Policy Target Audience All Clinical Staff Version 1.0 November 2015 Infection Prevention and Control Assurance Policy Ref. Contents Page

More information

MRSA INFORMATION LEAFLET for patients and relatives. both in hospital and the community. MRSA is a type of

MRSA INFORMATION LEAFLET for patients and relatives. both in hospital and the community. MRSA is a type of MRSA INFORMATION LEAFLET for patients and relatives WHAT DOES MRSA STAND FOR? Meticillin Resistant Staphylococcus aureus. WHAT IS MRSA? Staphylococcus aureus is a germ that is commonly found both in hospital

More information

SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS (VRE)

SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS (VRE) SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS () Introduction Definitions Associated with Risk Groups Signs and Symptoms Source Mode of Transmission Diagnosis Treatment Screening Transport Communication

More information

The Management of Extended Spectrum Beta Lactamase-Producing Organisms Policy. Infection Prevention and Control

The Management of Extended Spectrum Beta Lactamase-Producing Organisms Policy. Infection Prevention and Control The Management of Extended Spectrum Beta Lactamase-Producing Organisms Policy Infection Prevention and Control This policy describes the key processes and protocols for patients colonised or infected with

More information

National Standards for the prevention and control of healthcare-associated infections in acute healthcare services.

National Standards for the prevention and control of healthcare-associated infections in acute healthcare services. National Standards for the prevention and control of healthcare-associated infections in 2017 1 Safer Better Care Note on terms and abbreviations used in these standards A full range of terms and abbreviations

More information

Checklists for Preventing and Controlling

Checklists for Preventing and Controlling Checklists for Preventing and Controlling Clostridium difficile Infection (CDI) This document has been developed to specifically assist senior management and all ward staff to take appropriate actions,

More information

Preventing Further Spread of CPE

Preventing Further Spread of CPE Provisional Guidance relating to CPE for General Practice. May 26 2017. Issued by the HSE Health Care Associated Infection and Antimicrobial Resistance Response Team. What is CPE (Carbapenemase Producing

More information

Preventing Cross-infection Patricia Folan and Lesley Baillie

Preventing Cross-infection Patricia Folan and Lesley Baillie CHAPTER 3 Preventing Cross-infection Patricia Folan and Lesley Baillie Preventing cross-infection is an essential activity for all nurses in their everyday practice. Nurses have an ethical and legal duty

More information

Objectives. Industry Landscape. Infection Prevention and Control Changes, Updates and Quality Results!

Objectives. Industry Landscape. Infection Prevention and Control Changes, Updates and Quality Results! Infection Prevention and Control Changes, Updates and Quality Results! Sue LaGrange, RN, BSN, NHA, CDONA, FACDONA, CIMT Director of Education Pathway Health 1 Objectives 1.Describe the recent industry

More information

Glycopeptide/Vancomycin Resistant Enterococci (GRE/VRE) Policy

Glycopeptide/Vancomycin Resistant Enterococci (GRE/VRE) Policy Glycopeptide/Vancomycin Resistant Enterococci (GRE/VRE) Policy Post holder responsible for Procedural Document Author of Policy Division/ Department responsible for Procedural Document Contact details

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Animals on Hospital Premises Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Animals on Hospital Premises Policy The Newcastle upon Tyne Hospitals NHS Foundation Trust Animals on Hospital Premises Policy Version No. 6.0 Effective From: 16 March 2018 Expiry Date: 16 March 2021 Date Ratified: 06 March 2018 Ratified

More information

Standard Precautions for Infection Control

Standard Precautions for Infection Control Standard Precautions for Infection Control Author(s) & Designation Lead Clinician if appropriate In consultation with To be read in association with Ratified by Suzanne Golding-Ellis, Head of Patient Safety

More information

Annual Infection Prevention and Control Report Produced by Colette Thomas Lead Nurse Infection Prevention and Control Page 1

Annual Infection Prevention and Control Report Produced by Colette Thomas Lead Nurse Infection Prevention and Control Page 1 Infection Prevention And Control Annual Report 2014-2015 Presented by: Written and Compiled by: Contributors: Executive Lead: Director of Infection Prevention and Control Lead Nurse, Infection Prevention

More information

INFECTION CONTROL SURVEILLANCE POLICY

INFECTION CONTROL SURVEILLANCE POLICY INFECTION CONTROL SURVEILLANCE POLICY Version: 3 Ratified by: Date ratified: July 2016 Title of originator/author: Title of responsible committee/group: Senior Managers Operational Group Head of Infection

More information

Prairie North Regional Health Authority: Hospital-acquired infections

Prairie North Regional Health Authority: Hospital-acquired infections Prairie North Regional Health Authority: Hospital-acquired infections Main points... 308 Introduction... 309 Background the risk of hospital-acquired infections... 309 Audit objective, scope, criteria,

More information

Protocol for the Prevention and Management of Clostridium difficile.

Protocol for the Prevention and Management of Clostridium difficile. Protocol for the Prevention and Management of Clostridium difficile. Policy Profile Policy Reference: Clinical care protocol 14. App D Clin 2.0 Version: Version 2.1 Author: Selma Mehdi, Lead Nurse Infection

More information

Section J - Management of Patients with Multi Resistant Organisms:

Section J - Management of Patients with Multi Resistant Organisms: Section J - Management of Patients with Multi Resistant Organisms: Carbapenemase-Producing Enterobacteriaceae (CPE) Vancomycin-Resistant Enterococci (VRE) Penicillin-Resistant Pneumococci (PRP) Extended

More information

Developed in response to: Health and Social Care Act 2008 Contributes CQC Core Standard Outcome 8

Developed in response to: Health and Social Care Act 2008 Contributes CQC Core Standard Outcome 8 GRE (Glycopeptide Resistant Enterococci) Clinical Guideline Register No: 08028 Status: Public Developed in response to: Health and Social Care Act 2008 Contributes CQC Core Standard Outcome 8 Consulted

More information

Five Top Tips to Prevent Infections in Long-term Care Settings

Five Top Tips to Prevent Infections in Long-term Care Settings Five Top Tips to Prevent Infections in Long-term Care Settings Tip No. 1 Vigilance Open Your Eyes Staff Education Reduce Risks Be Proactive Know the Signs and Symptoms of Infection Tip No. 2 Hand Hygiene

More information

INFECTION C ONTROL CONTROL CONTROL EDUCATION PROGRAM

INFECTION C ONTROL CONTROL CONTROL EDUCATION PROGRAM INFECTION CONTROL EDUCATION PROGRAM Isolation Precautions Isolating the disease not the patient The Purpose is To protect compromised patient from environment To prevent the spread of communicable diseases.

More information

NHS GREATER GLASGOW & CLYDE CONTROL OF INFECTION COMMITTEE STANDARD OPERATING PROCEDURE (SOP) GROUP A STREPTOCOCCUS (Streptococcus pyogenes)

NHS GREATER GLASGOW & CLYDE CONTROL OF INFECTION COMMITTEE STANDARD OPERATING PROCEDURE (SOP) GROUP A STREPTOCOCCUS (Streptococcus pyogenes) Page Page 1 of 9 SOP Objective To ensure Healthcare Workers (HCWs) are aware of the actions and precautions necessary to minimise the risk of cross-infection and the importance of diagnosing patients clinical

More information

TRANSMISSION-BASED PRECAUTIONS

TRANSMISSION-BASED PRECAUTIONS TRANSMISSION-BASED PRECAUTIONS PRECAUTIONS Standard Precautions infection prevention practices used with all patients regardless of suspected or confirmed diagnosis. Based on the principle that all blood,

More information

The Newcastle upon Tyne NHS Hospitals Foundation Trust. Latex Operational Policy

The Newcastle upon Tyne NHS Hospitals Foundation Trust. Latex Operational Policy The Newcastle upon Tyne NHS Hospitals Foundation Trust Version No.: 4.2 Effective From: 27 October 2015 Expiry Date: 27 October 2018 Date Ratified: 1 July 2015 Ratified By: Clinical Risk Group 1 Introduction

More information

NOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION

NOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION NOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION DR AHMAD SHALTUT OTHMAN JAB ANESTESIOLOGI & RAWATAN RAPI HOSP SULTANAH BAHIYAH ALOR SETAR, KEDAH Nosocomial infection Nosocomial or hospital

More information

Management of Patients with Diarrhoea

Management of Patients with Diarrhoea Management of Patients with Diarrhoea Reference No: Version: 1 Ratified by: G_IPC_45 LCHS Trust Board Date Ratified: 12 th January 2016 Name of originator/author: Name of responsible committee/individual:

More information

The Clatterbridge Cancer Centre. NHS Foundation Trust MRSA. Infection Control. A guide for patients and visitors

The Clatterbridge Cancer Centre. NHS Foundation Trust MRSA. Infection Control. A guide for patients and visitors The Clatterbridge Cancer Centre NHS Foundation Trust MRSA Infection Control A guide for patients and visitors Contents Information... 1 Symptoms... 1 Diagnosis... 2 Treatment... 2 Prevention of spread...

More information

HCAI Local implementation team action plan

HCAI Local implementation team action plan HCAI Local implementation team action plan Item Type Report Authors New Governance HCAI Group Publisher New Governance HCAI Group Download date 16/09/2018 18:12:09 Link to Item http://hdl.handle.net/10147/110814

More information

Northumbria Healthcare NHS Foundation Trust. Infection Control Information for Patients and Visitors. Issued by The Infection Control Team

Northumbria Healthcare NHS Foundation Trust. Infection Control Information for Patients and Visitors. Issued by The Infection Control Team Northumbria Healthcare NHS Foundation Trust Infection Control Information for Patients and Visitors Issued by The Infection Control Team Introduction The purpose of this leaflet is to help you understand

More information

The most up to date version of this policy can be viewed at the following website:

The most up to date version of this policy can be viewed at the following website: Page Page 1 of 6 Policy Objective To ensure that HCWs are aware of the actions and precautions necessary to minimise the risk of cross-infection and the importance of diagnosing patients clinical conditions

More information

Other (please specify): Note: This document has been assessed for any equality, diversity or human rights implications

Other (please specify): Note: This document has been assessed for any equality, diversity or human rights implications Post holder responsible for Procedural Document Author of Policy Division/ Department responsible for Procedural Document Contact details Nicola Colborne, Infection Prevention and Control Nurse Specialist

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy The Newcastle upon Tyne Hospitals NHS Foundation Trust Water Safety Policy Version No.: 2.0 Effective From: 09 February 2018 Expiry Date: 09 February 2021 Date Ratified: 09 November 2017 Ratified By: Infection

More information

Open and Honest Care in your Local Hospital

Open and Honest Care in your Local Hospital Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support organisations to become more transparent and consistent in publishing safety, experience

More information

Learning Resource Pack: Source Isolation Version 2 (Aug 2005)

Learning Resource Pack: Source Isolation Version 2 (Aug 2005) 0 Contents.. Page No. Introduction 2 Assessment Activities 3 Aim and Learning Outcomes 4 Topic Sequencing Diagram 5 Section 1: What is Source Isolation? 6 Assessment Activity 1 8 Section 2: Principles

More information

Infection Prevention and Control

Infection Prevention and Control Infection Prevention and Control Infection Prevention and Control Program IPAC program consists of three healthcare professionals IPAC department is located on the 9 th floor and is available Monday to

More information

General Practice Template. Guidelines for the Management of cases & outbreaks of Norovirus

General Practice Template. Guidelines for the Management of cases & outbreaks of Norovirus General Practice Template Guidelines for the Management of cases & outbreaks of Norovirus Title: Procedural Document Type: Reference: Version: Ratified by: Date ratified: Freedom of Information: Name of

More information

Assessing Evidence of Transmission and End of Transmission of Carbapenemase Producing Enterobacterales 1 (CPE)

Assessing Evidence of Transmission and End of Transmission of Carbapenemase Producing Enterobacterales 1 (CPE) Assessing Evidence of Transmission and End of Transmission of Carbapenemase Producing Enterobacterales 1 (CPE) CPE Expert Group National Guidance Document, Version 1.0 Scope of this Guidance This guidance

More information

Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE)

Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE) Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE) Author: Responsible Lead Executive Director: Endorsing Body: Governance or Assurance

More information

Enterobacteriaceae. Preventing the Spread of Carbapenemresistant. in LTCFs. Nimalie D. Sto ne, MD, MS CDC Division of Healthcare Quality Promotion

Enterobacteriaceae. Preventing the Spread of Carbapenemresistant. in LTCFs. Nimalie D. Sto ne, MD, MS CDC Division of Healthcare Quality Promotion Preventing the Spread of Carbapenemresistant Enterobacteriaceae in LTCFs Nimalie D. Sto ne, MD, MS CDC Division of Healthcare Quality Promotion March 29, 2016 Preventing the Spread of Carbapenemresistant

More information

What you can do to help stop the spread of MRSA and other infections

What you can do to help stop the spread of MRSA and other infections MRSA wash it away As a patient it is important that you get better quickly and stay well. This leaflet gives you information about MRSA and other health care associated infections, so that you know what

More information

Antibiotic Use and Resistance in Nursing Homes

Antibiotic Use and Resistance in Nursing Homes Antibiotic Use and Resistance in Nursing Homes GHINWA DUMYATI, MD PROFESSOR OF MEDICINE CENTER FOR COMMUNITY HEALTH UNIVERSITY OF ROCHESTER MEDICAL CENTER FEBRUARY 8, 2017 Nicolle LE, et al. Antimicrobial

More information

Open and Honest Care in your Local Hospital

Open and Honest Care in your Local Hospital Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support The Open and Honest Care: Driving Improvement organisations to become more transparent

More information

Infection Control Prevention Strategies. For Clinical Personnel

Infection Control Prevention Strategies. For Clinical Personnel Infection Control Prevention Strategies For Clinical Personnel What is Infection Control? Infection Control is EVERYONE s responsibility It protects patients, employees and visitors by preventing and controlling

More information

FF C.DIFF C.DIFF C CLOSTRIDIUM DIFFICILE INFECTION

FF C.DIFF C.DIFF C CLOSTRIDIUM DIFFICILE INFECTION IFF IFF DIFF. DIFF C. DIFF FF C.DIFF C.DIFF C CLOSTRIDIUM DIFFICILE INFECTION Information for patients, their families and carers. What does it mean if someone has Clostridium difficile, or C. diff? These

More information

Prevention and control of healthcare-associated infections

Prevention and control of healthcare-associated infections Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process

More information

Clostridium difficile policy

Clostridium difficile policy Clostridium difficile policy Document level: Trustwide (TW) Code: IC5 Issue number: 4 Lead executive Director of Infection, Prevention and Control Author and contact number Infection Prevention and Control

More information

Infection Prevention and Control Annual Report

Infection Prevention and Control Annual Report Infection Prevention and Control Annual Report 2015-16 Infection Prevention and Control Annual Report 2015-16 CONTENTS EXECUTIVE SUMMARY... 1 1. INTRODUCTION... 3 2. INFECTION PREVENTION AND CONTROL ARRANGEMENTS...

More information

Open and Honest Care in your Local Hospital

Open and Honest Care in your Local Hospital Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support The Open and Honest Care: Driving Improvement organisations to become more transparent

More information

Hereford Hospitals NHS Trust

Hereford Hospitals NHS Trust Hereford Hospitals NHS Trust Universal Meticillin Resistant Staphylococcus Aureus (MRSA) Screening Protocol IC.08 IF THIS DOCUMENT HAS BEEN PRINTED, IT SHOULD NOT BE ASSUMED TO BE THE LATEST VERSION. Document

More information

Infection Prevention and Control for Phlebotomy

Infection Prevention and Control for Phlebotomy Page 1 of 10 POLICY STATEMENT: It is Sunnybrook s Policy to prevent the spread of infection within the health care institution from patient to patient, patient to staff, staff to patient by: a) providing

More information

WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT

WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT 2006-2007 Author(s) Gill Harris, Director of Infection Prevention and Control EXECUTIVE

More information

Animals and Pets in Healthcare Facilities Policy

Animals and Pets in Healthcare Facilities Policy Animals and Pets in Healthcare Facilities Policy Post holder responsible for Procedural Document Author of Guideline Division/ Department responsible for Procedural Document Contact details Judy Potter,

More information

MRSA. Information for patients and carers. Delivering the best in care. UHB is a no smoking Trust

MRSA. Information for patients and carers. Delivering the best in care. UHB is a no smoking Trust MRSA Information for patients and carers Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm

More information

Clostridium difficile Infection (CDI) Trigger Tool

Clostridium difficile Infection (CDI) Trigger Tool Hospital ward/clinical Area Date Trigger Tool Commenced Date Trigger Tool Closed Person closing the CDI Trigger Health Protection Scotland March 2014 Version 3.0 A CDI trigger is the number of new CDI

More information

Healthcare-Associated Infections

Healthcare-Associated Infections Healthcare-Associated Infections A healthcare crisis requiring European leadership Healthcare-associated infections (HAIs - also referred to as nosocomial infections) are defined as an infection occurring

More information

Report of the unannounced inspection at Wexford General Hospital.

Report of the unannounced inspection at Wexford General Hospital. Report of the unannounced inspection of the prevention and control of healthcare associated infection at X Hospital Report of the unannounced inspection at Wexford General Hospital. Monitoring programme

More information

Open and Honest Care in your Local Hospital

Open and Honest Care in your Local Hospital Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support organisations to become more transparent and consistent in publishing safety, experience

More information

THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION

THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION THE HYGIENE CODE : ACUTE TRUST AND COMMUNITY HEALTH DIVISION Compliance 1) Systems to manage and monitor the prevention and control of infection. These systems use risk assessments and consider how susceptible

More information

Infection Prevention and Control Policy

Infection Prevention and Control Policy Infection Prevention and Control Policy March 2012 Ref: PCD053 (v5) Status: Infection Prevention and Control Policy Policy Reference Number IC017 Status Version 5 Implementation Date September 2007 Current/Last

More information

Recommendations: Board members are requested to note the content of the report and priority areas for the coming year.

Recommendations: Board members are requested to note the content of the report and priority areas for the coming year. Trust Board Date: 24/05/2017 Purpose of the Report: Item: Annual Report Infection Prevention & Control. Enclosure: The Trust Board are provided with the Annual Report of Infection Prevention & Control

More information